Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Clin Lung Cancer. 2016 Jun 27;18(1):5–12. doi: 10.1016/j.cllc.2016.06.007

Table 1.

Cooperative Group Trials Currently Accruing

Study National Clinical
Trial Identifier
NSCLC
  EA4512 (ALCHEMIST) NCT02201992
  A081105 (ALCHEMIST) NCT02193282
  EA5142 (ANVIL) NCT02595944
  RTOG 1308 NCT01993810
  RTOG 1106 NCT01507428
  RTOG 1306 NCT01822496
  S1400 (Lung-MAP) NCT02154490
  S1403 NCT02438722
  CALGB 140503 NCT00499330
  AFT-09 NCT02591615
  ACCRU RC1126 NCT01532089
  CTONG 1103 (EMERGING) NCT01407822
  CTONG 1104 (ADJUVANT) NCT01405079
  EORTC 22055-08053 (LUNG ART) NCT00410683
  EORTC 08114 (GEM) NCT01838577
  BR31 NCT02273375
  IND219 NCT02337530
SCLC
  CALGB 30610/RTOG 0538 NCT00632853
  ETOP 4-13 (STIMULI) NCT02046733
Mesothelioma
  CALGB 30901 NCT01085630

Abbreviations: NSCLC = non–small-cell lung cancer; SCLC = small-cell lung cancer.